LY294002, an inhibitor of phosphatidylinositol-3-kinase, causes preferential induction of apoptosis in human multidrug resistant cells

被引：19

作者：

Nicholson, KM ^{[1
]}

Quinn, DM ^{[1
]}

Kellett, GL ^{[1
]}

Warr, JR ^{[1
]}

机构：

[1] Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England

来源：

CANCER LETTERS | 2003年 / 190卷 / 01期

关键词：

LY294002; multidrug resistance; apoptosis;

D O I：

10.1016/S0304-3835(02)00615-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Protein kinase B (PKB), a kinase downstream of phosphatidylinositol 3-kinase (PI3-kinase) provides anti-apoptotic and survival signals via phosphorylation of various targets. Inhibiting PI3-kinase with a 12 h exposure to 10 muM LY294002 induces levels of apoptosis of 30.39 +/- 1.53% in the KB-V1 multidrug resistant (MDR) cell line compared to 4.54 +/- 1.00% in drug sensitive KB-3-1 cells (P < 0.001). This occurred in conjunction with a preferential reduction in activated PKB in MDR cells. These results suggest the PI3-kinase/PKB signalling pathway is important for the survival of MDR cells and inhibition of this pathway results in the selective induction of apoptosis in MDR cells. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.

引用

页码：31 / 36

页数：6

共 50 条

[41] Fisetin targets phosphatidylinositol-3-kinase and induces apoptosis of human B lymphoma Raji cells
Lim, Ji Yeon
Lee, Joo Yun
Byun, Byung Jin
Kim, Seong Hwan
TOXICOLOGY REPORTS, 2015, 2 : 984 - 989
[42] Chronic treatment with LY294002, an inhibitor of phosphatidylinositol 3-kinase, attenuates ischemia/reperfusion-induced cardiac dysfunction in normotensive and hypertensive diabetic animals
Benter, Ibrahim F.
Al-Rashdan, Ibrahim
Juggi, Jasbir S.
Yousif, Mariam H. M.
Akhtar, Saghir
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2013, 373 (1-2) : 259 - 264
[43] Chronic treatment with LY294002, an inhibitor of phosphatidylinositol 3-kinase, attenuates ischemia/reperfusion-induced cardiac dysfunction in normotensive and hypertensive diabetic animals
Ibrahim F. Benter
Ibrahim Al-Rashdan
Jasbir S. Juggi
Mariam H. M. Yousif
Saghir Akhtar
Molecular and Cellular Biochemistry, 2013, 373 : 259 - 264
[44] LY294002 inhibits monocyte chemoattractant protein-1 expression through a phosphatidylinositol 3-kinase-independent mechanism
Choi, EK
Park, HJ
Ma, JS
Lee, HC
Kang, HC
Kim, BG
Kang, IC
FEBS LETTERS, 2004, 559 (1-3) : 141 - 144
[45] GSK-3β reactivation with LY294002 sensitizes hepatoma cells to chemotherapy-induced apoptosis
Beurel, E
Kornprobst, M
Eggelpoël, MJBV
Cadoret, A
Capeau, J
Desbois-Mouthon, C
INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 27 (01) : 215 - 222
[46] Radiosensitization of human tumor cells by the phosphatidylinositol 3-kinase inhibitors Wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G(2)-M delay
Rosenzweig, KE
Youmell, MB
Palayoor, ST
Price, BD
CLINICAL CANCER RESEARCH, 1997, 3 (07) : 1149 - 1156
[47] LY294002 inhibits the malignant phenotype of osteosarcoma cells by modulating the phosphatidylinositol 3-kinase/Akt/fatty acid synthase signaling pathway in vitro
Zhou, Yang
Zhu, Liang Bo
Peng, Ai Fen
Wang, Tao Fang
Long, Xin Hua
Gao, Song
Zhou, Rong Ping
Liu, Zhi Li
MOLECULAR MEDICINE REPORTS, 2015, 11 (02) : 1352 - 1357
[48] Activating transcription factor 3 and early growth response 1 are the novel targets of LY294002 in a phosphatidylinositol 3-kinase-independent pathway
Yamaguchi, K
Lee, SH
Kim, JS
Wimalasena, J
Kitajima, S
Baek, SJ
CANCER RESEARCH, 2006, 66 (04) : 2376 - 2384
[49] Phosphatidylinositol-3-kinase inhibitor LY 294002 blocks Streptococcus mutans-induced interleukin (IL)-6 and IL-8 gene expression in odontoblast-like cells
Dommisch, H.
Steglich, M.
Eberhard, J.
Winter, J.
Jepsen, S.
INTERNATIONAL ENDODONTIC JOURNAL, 2008, 41 (09) : 763 - 771
[50] The phosphatidylinositol 3-kinase inhibitor LY 294002 inhibits GlyT1-mediated glycine uptake
Wu, Zhi-Liang
O'Kane, Teresa M.
Connors, Thomas J.
Marino, Michael J.
Schaffhauser, Herve
BRAIN RESEARCH, 2008, 1227 : 42 - 51

← 1 2 3 4 5 →